Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease

NCT00529568 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

759

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: eltrombopag
DRUG: placebo

Sponsor

GlaxoSmithKline